jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

Oct. 17, 2025

Feb. 13, 2026

jRCT2051250132

Pharmacokinetic study of STN1014003 ophthalmic solution in healthy male adults

Pharmacokinetic study of STN1014003 ophthalmic solution in healthy male adults

Sakamoto Kayoko

Santen pharmaceutical co.,ltd

4-20 Ofuka-cho, Kita-ku, Osaka, Japan

+81-6-4802-9341

clinical@santen.co.jp

Sakamoto Kayoko

Santen pharmaceutical co.,ltd

4-20 Ofuka-cho, Kita-ku, Osaka, Japan

+81-6-4802-9341

clinical@santen.co.jp

Complete

Oct. 16, 2025

Nov. 09, 2025
8

Interventional

single arm study

open(masking not used)

uncontrolled control

single assignment

treatment purpose

Subjects who can comply with scheduled visits and the examination and observation as specified in the clinical study protocol

1)Subjects have a disease and/or abnormal laboratory value which is considered inappropriate from safety evaluation perspective
2)Subjects who are inappropriate as participants in this study in the opinion of the investigator or sub investigator

18age old over
35age old under

Male

Open angle glaucoma (OAG) or Ocular hypertension (OHT)

STN1014003 ophthalmic solution , 1 drop once daily for 8days

Plasma pharmacokinetics

Santen pharmaceutical co.,ltd
Medical Corporation Heishinkai OPHAC Hospital IRB
4-1-29 Miyahara Yodogawa-ku, Osaka-shi, Osaka, Japan, Osaka

+81-6-6395-9000

ophach_irb@heishinkai.com
Approval

Oct. 09, 2025

No

none

History of Changes

No Publication date
3 Feb. 13, 2026 (this page) Changes
2 Nov. 10, 2025 Detail Changes
1 Oct. 17, 2025 Detail